These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10727535)

  • 1. STOPPING at the CAPPP of good HOPE.
    Luft FC
    Nephrol Dial Transplant; 2000 Apr; 15(4):451-2. PubMed ID: 10727535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Control of blood pressure in prevention of hypertensive end-organ damage].
    Kido M; Ando K; Fujita T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():389-93. PubMed ID: 15171405
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomized trial. The Captopril Prevention Project (CAPP) Study Group.
    Curr Hypertens Rep; 1999 Dec; 1(6):466-7. PubMed ID: 11041675
    [No Abstract]   [Full Text] [Related]  

  • 4. CAPPP trial. Captopril Prevention Project.
    Brown J; Brown MJ
    Lancet; 1999 May; 353(9166):1795-6. PubMed ID: 10348013
    [No Abstract]   [Full Text] [Related]  

  • 5. CAPPP trial. Captopril Prevention Project.
    Wiggam MI; Atkinson AB; Bell PM
    Lancet; 1999 May; 353(9166):1794; author reply 1795-6. PubMed ID: 10348011
    [No Abstract]   [Full Text] [Related]  

  • 6. CAPPP trial. Captopril Prevention Project.
    Messerli FH; Grossman E
    Lancet; 1999 May; 353(9166):1794-5; author reply 1795-6. PubMed ID: 10348012
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
    Hansson L; Lindholm LH; Niskanen L; Lanke J; Hedner T; Niklason A; Luomanmäki K; Dahlöf B; de Faire U; Mörlin C; Karlberg BE; Wester PO; Björck JE
    Lancet; 1999 Feb; 353(9153):611-6. PubMed ID: 10030325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of the month. The CAPPP study: "The Captopril Prevention Project"].
    Scheen AJ
    Rev Med Liege; 1999 Mar; 54(3):197-9. PubMed ID: 10321112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Back to basics: diuretics as first-line agents in the treatment of hypertension.
    Mandal VJ
    J Am Geriatr Soc; 2004 Jul; 52(7):1210-1. PubMed ID: 15209664
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effects of diuresis and beta-adrenoreceptor blockade during angiotensin-converting enzyme inhibition in patients with severe hypertension.
    Drayer JI; Weber MA; Lipson JL; Megaffin BB
    J Clin Pharmacol; 1982 Apr; 22(4):179-86. PubMed ID: 6124556
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of ACE inhibitors on cardiovascular morbidity and mortality.
    Hachey D; Force RW
    J Fam Pract; 1999 Jun; 48(6):414-5. PubMed ID: 10386477
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of first-line antihypertensives.
    Strickland C
    J Fam Pract; 1997 Jun; 44(6):530-1. PubMed ID: 9191619
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure--meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Mar; 34(3):373-84; discussion 384. PubMed ID: 26780184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Do ACE inhibitors reduce morbidity and mortality in arterial hypertension?].
    Ritzmann P
    Praxis (Bern 1994); 1999 Nov; 88(48):2005-6. PubMed ID: 10608185
    [No Abstract]   [Full Text] [Related]  

  • 15. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
    Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
    [No Abstract]   [Full Text] [Related]  

  • 16. [Administration of beta blockers for chronic heart failure].
    Walma EP
    Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2325-6. PubMed ID: 11143301
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent intervention trials in hypertension initiated in Sweden--HOT, CAPPP and others. Hypertension Optimal Treatment Study. Captopril Prevention Project.
    Hansson L
    Clin Exp Hypertens; 1999; 21(5-6):507-15. PubMed ID: 10423077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
    Bath P
    Stroke; 2003 May; 34(5):1334-5. PubMed ID: 12702833
    [No Abstract]   [Full Text] [Related]  

  • 19. Heart failure: Part II.
    Wilkes MS; Middlekauff H; Hoffman JR
    West J Med; 1999 Jun; 170(6):339-42. PubMed ID: 10443162
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination therapy of beta blockers for heart failure].
    Watanabe M; Hirata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():129-33. PubMed ID: 17571376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.